Dr. Markus Jorger, MD
Claim this profileKantonsspital St. Gallen
Area of expertise
Colon Cancer
Markus Jorger, MD has run 1 trial for Colon Cancer. Some of their research focus areas include:
Lung Cancer
Markus Jorger, MD has run 1 trial for Lung Cancer. Some of their research focus areas include:
More about Markus Jorger, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Markus Jorger, MD has experience with
- IP-001
Breakdown of trials Markus Jorger, MD has run
Colon Cancer
Soft Tissue Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Markus Jorger, MD specialize in?
Markus Jorger, MD focuses on Colon Cancer and Lung Cancer. In particular, much of their work with Colon Cancer has involved Stage IV patients, or patients who are Stage III.
Is Markus Jorger, MD currently recruiting for clinical trials?
No, Markus Jorger, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Markus Jorger, MD has studied deeply?
Yes, Markus Jorger, MD has studied treatments such as IP-001.
What is the best way to schedule an appointment with Markus Jorger, MD?
Apply for one of the trials that Markus Jorger, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.